CAMLINFINE Camlin Fine Q3 FY26 results (Oct–Dec 2025) and concall
Camlin Fine Sciences reported a Q3 FY26 turnover of ₹572 crores, a 6% YoY increase, but faced EBITDA margin compression to 6.7% due to challenges in the Straights business and fixed cost absorption. The company is strategically positioning for future growth with a significant Vanillin volume target of 4,000 metric tons for FY27 and 25% growth in Blends, despite managing the impact of a fire incident in Brazil and ongoing liquidation processes for European and Chinese entities.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 2.3%, net profit down 428.6% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 417 | 431 | 432 | 408 | 460 +10% | 441 +2% |
| EBITDA | 52 | 56 | 62 | 20 | 33 −37% | 21 −62% |
| Net profit | -116 | -7 | 0 | -11 | -15 +87% | -37 −429% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
